Израиль -
английский -
Ministry of Health
prograf 5 mg
astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.
Израиль -
английский -
Ministry of Health
prograf 5 mg
astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.
Израиль -
английский -
Ministry of Health
prograf 0.5 mg
astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.
Израиль -
английский -
Ministry of Health
prograf 0.5 mg
astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.
Европейский союз -
английский -
EMA (European Medicines Agency)
protopy
astellas pharma gmbh - tacrolimus - dermatitis, atopic - other dermatological preparations - treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. treatment of moderate to severe atopic dermatitis in children (2 years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids.maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).
Ирландия -
английский -
HPRA (Health Products Regulatory Authority)
vesitirim 5 mg film-coated tablets
astellas pharma co. limited - solifenacin succinate - film-coated tablet - 5 milligram(s) - drugs for urinary frequency and incontinence; solifenacin
Ирландия -
английский -
HPRA (Health Products Regulatory Authority)
vesitirim 10 mg film-coated tablets
astellas pharma co. limited - solifenacin succinate - film-coated tablet - 10 milligram(s) - drugs for urinary frequency and incontinence; solifenacin
Ирландия -
английский -
HPRA (Health Products Regulatory Authority)
vesomni 6 mg/0.4 mg modified-release tablets
astellas pharma co. limited - solifenacin succinate; tamsulosin hydrochloride - modified-release tablet - 6 mg/0.4 milligram(s) - drugs for urinary frequency and incontinence; solifenacin
Ирландия -
английский -
HPRA (Health Products Regulatory Authority)
omnexel®, 400 micrograms prolonged release tablets, film-coated
astellas pharma co. limited - tamsulosin hydrochloride - prolonged-release tablet - 400 microgram(s) - alpha-adrenoreceptor antagonists; tamsulosin
Ирландия -
английский -
HPRA (Health Products Regulatory Authority)
vesikur tablets 5 milligram
astellas pharma co. ltd - solifenacin succinate - tablets - 5 milligram